Could probiotic capsules beat bacterial vaginosis?

NCT ID NCT07418918

Completed Disease control Sponsor: Guangdong Longchuangji Pharmaceutical Co., Ltd. Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether vaginal capsules containing two types of Lactobacillus probiotics can treat bacterial vaginosis, a common vaginal infection. Sixty-six women received either the probiotic capsule or a placebo. The goal was to see if the probiotics could restore normal vaginal conditions and clear the infection. Results may point to a gentler alternative to antibiotics.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Lactobacillus dual probiotic vaginal capsules
What this could lead to: If it works, this could provide a new, non-antibiotic treatment for bacterial vaginosis, helping restore natural vaginal balance.
What could go wrong: This is a small Phase 2 trial, so results may not confirm effectiveness. The placebo group also shows improvement in some studies, and long-term benefits are unknown.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BACTERIAL VAGINOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

bacterial vaginosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BACTERIAL VAGINOSIS

Contacts and locations

Locations

Guangdong Longchuangji Pharmaceutical Co., Ltd.

Chaozhou, Guangdong, 521000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.